2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Terminated
1
Sponsor Class
OTHER
2
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Lymphoid
2
Conditions
Brain Neoplasms
5
Glioma
4
Breast Neoplasms
4
Prostatic Neoplasms
2
Neoplasms
2
Lymphoma, Large B-Cell, Diffuse
2
Vision Disorders
1
Uterine Cervical Neoplasms
1
Turcot syndrome
1
Tongue Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Salivary Gland Neoplasms
1
Rectal Neoplasms
1
Pituitary Neoplasms
1
Peripheral Nervous System Diseases
1
Oligodendroglioma
1
Neurotoxicity Syndromes
1
Neuritis
1
Neoplasm Metastasis
1
Medulloblastoma
1
Mediastinal Neoplasms
1
Lymphedema
1
Lung Neoplasms
1
Head and Neck Neoplasms
1
Gliosarcoma
1
Glioblastoma
1
Familial ependymoma
1
Esthesioneuroblastoma, Olfactory
1
Ependymoma
1
Diffuse Intrinsic Pontine Glioma
1
Interventions
Rituximab
416
Cyclophosphamide
348
Vincristine
173
Prednisone
172
Doxorubicin
168
Etoposide
160
Peripheral Blood Stem Cell Transplantation
114
Filgrastim
108
Lenalidomide
97
fludarabine phosphate
96
Radiotherapy
80
Cytarabine
80
Gemcitabine
73
Melphalan
66
Mycophenolic Acid
64
Cyclosporine
60
Methotrexate
59
Busulfan
57
Ifosfamide
55
Carmustine
55
fludarabine
50
Tacrolimus
50
Whole-Body Irradiation
49
Carboplatin
49
polatuzumab vedotin
44
Oxaliplatin
44
Dexamethasone
44
Antilymphocyte Serum
42
ibrutinib
40
Bendamustine Hydrochloride
40
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Lymphoma, Large B-Cell, Diffuse
×
Diffusion Tensor Imaging
×
Clear all
NCT03121456
2023-11-13
LYMPHODTECT
Centre Antoine Lacassagne
Phase NA
Unknown
74 enrolled
NCT00645359
2017-04-14
dMRI
University of Michigan Rogel Cancer Center
Terminated
9 enrolled
3 charts